Skip to content

Bradsher Neal C

Reporting owner on Forms 3, 4 and 5, CIK 1278388.

Bradsher Neal C reported on 2 issuers in 2 filings, the latest a Form 4 filed 2026-11-19.

Issuers

IssuerRoles in the latest filingFilingsLast filed
LCTX · Lineage Cell Therapeutics, Inc.CIK 876343director, 10% owner12026-11-19
IMDX · Insight Molecular Diagnostics Inc.CIK 164238010% owner12026-11-19

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
LCTX · Lineage Cell Therapeutics, …Common Shares2026-11-17P bought+1,000,000$0.770750,560,992Form 4
LCTX · Lineage Cell Therapeutics, …Common Shares2026-11-17P bought+0$050,560,992Form 4
LCTX · Lineage Cell Therapeutics, …Common Shares, holding 87,628Form 4
LCTX · Lineage Cell Therapeutics, …Common Warrant, derivative, holding 7,894,737Form 4
LCTX · Lineage Cell Therapeutics, …Common Warrant, derivative, holding 7,894,737Form 4
IMDX · Insight Molecular Diagnosti…Common Stock, no par value2026-11-17P bought+3,428,571$1.7516,113,455Form 4
IMDX · Insight Molecular Diagnosti…Common Stock, no par value2026-11-17P bought+0$016,113,455Form 4
IMDX · Insight Molecular Diagnosti…Common Stock, no par value, holding 157Form 4
IMDX · Insight Molecular Diagnosti…Warrant to Purchase Common Stock, derivative, holding 150,093Form 4
IMDX · Insight Molecular Diagnosti…Warrant to Purchase Common Stock, derivative, holding 150,093Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0000919574-26-008200 Lineage Cell Therapeutics, Inc.2026-11-19
Form 4 0000919574-26-008199 Insight Molecular Diagnostics Inc.2026-11-19